Compass Therapeutics, Inc.
CMPX · Biological Products, (No Diagnostic Substances) · 180.1M shares · EDGAR filings ↗
Reference price $1.89 · est. market cap ~$340M — last insider purchase, 2026-04-29 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — oncology clinical, very cash-rich.
Strengths
- Liquidity — current ratio 15.0 (93rd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- High convictionHigh conviction — notable institutional holders, insider buying, and a strong balance sheet
- Cash burnNegative free cash flow (-49.2M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $209M cash & investments, ~17 quarters of runway
- Insider buyingInsider buying — 2 open-market buy(s) by 2 insider(s) (cluster of 2 insiders, last 6mo) Form 4 ↗
- Notable holderHeld by 4 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, FMR LLC +1 more (as of 2026-03-31)
Key metrics
Return on equity
-33.8%
Return on assets
-30.3%
Current ratio
15.0×
Free cash flow
-$49M
EBITDA
-$73M
Tangible book value
$197M
Cash & investments
$209M
Cash runway
17q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-29 | Lerner Neil | Buy | 15K | $1.89 |
| 2026-04-29 | Anderman Jonathan | Buy | 25K | $1.89 |
| 2026-04-29 | Anderman Jonathan | Grant | 25K | $1.89 |
| 2026-04-29 | Lerner Neil | Grant | 15K | $1.89 |
| 2026-02-08 | Schuetz Thomas J. | Tax withheld | 37K | $6.52 |
| 2026-01-09 | Schuetz Thomas J. | Tax withheld | 47K | $5.35 |
| 2026-01-02 | Shin Barry | Grant | 125K | $5.17 |
| 2026-01-02 | Schuetz Thomas J. | Grant | 250K | $5.17 |
| 2026-01-02 | Lerner Neil | Grant | 62K | $5.17 |
| 2026-01-02 | Anderman Jonathan | Grant | 150K | $5.17 |
| 2025-11-16 | Schuetz Thomas J. | Tax withheld | 44K | $4.83 |
| 2025-05-27 | Schuetz Thomas J. | Buy | 10K | $2.11 |
| 2025-04-09 | GORDON CARL L | Sell | 3.6M | $1.59 |
| 2025-04-09 | ORBIMED ADVISORS LLC | Sell | 3.6M | $1.59 |
| 2025-04-07 | Anderman Jonathan | Buy | 20K | $1.54 |
| 2025-04-07 | Lerner Neil | Buy | 20K | $1.42 |
| 2025-02-08 | Schuetz Thomas J. | Tax withheld | 42K | $3.50 |
| 2025-01-09 | Schuetz Thomas J. | Tax withheld | 58K | $1.86 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-23 | 2026-06-22 | 0001171843-26-004224 ↗ |
| 8-K | 2026-06-11 | 2026-06-10 | 0001171843-26-004068 ↗ |
| 10-Q | 2026-05-05 | 2026-03-31 | 0001171843-26-003006 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0001171843-26-003005 ↗ |
| 8-K | 2026-04-27 | 2026-04-27 | 0001171843-26-002720 ↗ |
| 8-K | 2026-03-05 | 2026-03-05 | 0001171843-26-001336 ↗ |
| 10-K | 2026-03-05 | 2025-12-31 | 0001171843-26-001337 ↗ |
| 8-K | 2026-01-06 | 2026-01-06 | 0001171843-26-000083 ↗ |
| 8-K | 2025-11-05 | 2025-11-05 | 0001171843-25-007004 ↗ |
| 10-Q | 2025-11-05 | 2025-09-30 | 0001171843-25-007005 ↗ |
| 8-K | 2025-08-13 | 2025-08-12 | 0001193125-25-179958 ↗ |
| 10-Q | 2025-08-11 | 2025-06-30 | 0001171843-25-005261 ↗ |